FdaApplication
BLA 125117
Identifiers
- fda_app_no: BLA125117
Properties
| Property | Value |
|---|---|
| applicant_name | BioMarin Pharmaceutical Inc. |
| application_type | BLA |
| approval_date | 2005-05-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAGLAZYME | GALSULFASE | 5MG/5ML (1MG/ML) | INJECTABLE;INJECTION |
1 product